MANNKIND CORP Retained Earnings
MANNKIND CORP (MNKD) had Retained Earnings of -$3.23 billion as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-05
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$3.23B.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$3.21B.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$3.20B.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$3.18B.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$3.23B 10-Q · filed 2026-08-05 |
| 2026-03-31 | -$3.21B 10-Q · filed 2026-05-06 |
| 2025-12-31 | -$3.20B 10-Q · filed 2026-08-05 |
| 2025-09-30 | -$3.18B 10-Q · filed 2025-11-05 |
| 2025-06-30 | -$3.19B 10-Q · filed 2025-08-06 |
| 2025-03-31 | -$3.19B 10-Q · filed 2025-05-08 |
| 2024-12-31 | -$3.20B 10-K · filed 2026-02-26 |
| 2024-09-30 | -$3.21B 10-Q · filed 2024-11-07 |
| 2024-06-30 | -$3.22B 10-Q · filed 2024-08-07 |
| 2024-03-31 | -$3.22B 10-Q · filed 2024-05-08 |
| 2023-12-31 | -$3.23B 10-K · filed 2025-02-26 |
| 2023-09-30 | -$3.23B 10-Q · filed 2023-11-07 |
| 2023-06-30 | -$3.23B 10-Q · filed 2023-08-07 |
| 2023-03-31 | -$3.23B 10-Q · filed 2023-05-09 |
| 2022-12-31 | -$3.22B 10-K · filed 2024-02-27 |
| 2022-09-30 | -$3.20B 10-Q · filed 2022-11-08 |
| 2022-06-30 | -$3.19B 10-Q · filed 2022-08-09 |
| 2022-03-31 | -$3.16B 10-Q · filed 2022-05-05 |
| 2021-12-31 | -$3.13B 10-K · filed 2023-02-23 |
| 2021-09-30 | -$3.10B 10-Q · filed 2021-11-09 |
| 2021-06-30 | -$3.10B 10-Q · filed 2021-08-11 |
| 2021-03-31 | -$3.06B 10-Q · filed 2021-05-12 |
| 2020-12-31 | -$3.05B 10-K · filed 2022-02-24 |
| 2020-09-30 | -$3.02B 10-Q · filed 2020-11-04 |
| 2020-06-30 | -$3.01B 10-Q · filed 2020-08-05 |
| 2020-03-31 | -$3.00B 10-Q · filed 2020-05-06 |
| 2019-12-31 | -$2.99B 10-K · filed 2021-02-25 |
| 2019-09-30 | -$2.98B 10-Q · filed 2019-11-08 |
| 2019-06-30 | -$2.97B 10-Q · filed 2019-08-07 |
| 2019-03-31 | -$2.95B 10-Q · filed 2019-05-07 |
| 2018-12-31 | -$2.94B 10-K · filed 2020-02-25 |
| 2018-09-30 | -$2.93B 10-Q · filed 2018-11-01 |
| 2018-06-30 | -$2.91B 10-Q · filed 2018-08-02 |
| 2018-03-31 | -$2.88B 10-Q · filed 2018-05-09 |
| 2017-12-31 | -$2.85B 10-K · filed 2019-02-26 |
| 2017-09-30 | -$2.82B 10-Q · filed 2017-11-07 |
| 2017-06-30 | -$2.79B 10-Q · filed 2017-08-07 |
| 2017-03-31 | -$2.75B 10-Q · filed 2017-05-10 |
| 2016-12-31 | -$2.74B 10-K · filed 2018-02-27 |
| 2016-09-30 | -$2.79B 10-Q · filed 2016-11-09 |
| 2016-06-30 | -$2.92B 10-Q/A · filed 2016-08-10 |
| 2016-03-31 | -$2.89B 10-Q · filed 2016-05-09 |
| 2015-12-31 | -$2.86B 10-K · filed 2017-03-16 |
| 2015-09-30 | -$2.59B 10-Q · filed 2015-11-09 |
| 2015-06-30 | -$2.55B 10-Q · filed 2015-08-10 |
| 2015-03-31 | -$2.53B 10-Q · filed 2015-05-11 |
| 2014-12-31 | -$2.49B 10-K · filed 2016-03-15 |
| 2013-12-31 | -$2.30B 10-K · filed 2015-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |